These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30551443)

  • 1. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice.
    Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H
    Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
    Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
    Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
    Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
    Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
    Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
    Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
    Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
    OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
    Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance.
    Shahine Y; El-Aal SAA; Reda AM; Sheta E; Atia NM; Abdallah OY; Ibrahim SSA
    Inflammopharmacology; 2023 Jun; 31(3):1341-1359. PubMed ID: 37010718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutaecarpine ameliorates imiquimod-induced psoriasis-like dermatitis in mice associated with alterations in the gut microbiota.
    Li Y; Tan Z; Li W; Li Z; Zhang G
    Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):345-355. PubMed ID: 38419497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T
    Garzorz-Stark N; Lauffer F; Krause L; Thomas J; Atenhan A; Franz R; Roenneberg S; Boehner A; Jargosch M; Batra R; Mueller NS; Haak S; Groß C; Groß O; Traidl-Hoffmann C; Theis FJ; Schmidt-Weber CB; Biedermann T; Eyerich S; Eyerich K
    J Allergy Clin Immunol; 2018 Apr; 141(4):1320-1333.e11. PubMed ID: 28935206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Esculentoside reduces expression of Th17 cell-related cytokines in the imiquimod-induced psoriasis-like dermatitis mouse model].
    Lyu R; Feng F; Feng Z; Ma T; Lyu R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):595-600. PubMed ID: 31537243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
    Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
    Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
    Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.